SCHEMBL834024

SCHEMBL834024

C1=CC=C(C2=CC=CC=CCC2)CCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL834023 1.00
Pyrazine SCHEMBL28349072 0.88
SCHEMBL2770773 0.88
SCHEMBL8514541 0.86
SCHEMBL8395057 0.84
SCHEMBL8357521 0.84
SCHEMBL27637323 0.80
SCHEMBL11594509 0.79
SCHEMBL11594512 0.79
SCHEMBL121790 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023228075-A1 MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS INV NYLON CHEMICALS AMERICAS, LLC (US) 2023-11-30 WO claimed
CN-110632207-B Method for identifying mold based on volatile gas components and evolution trend thereof 南京财经大学 2022-04-29 CN claimed
CN-110632207-A Method for identifying mold based on volatile gas components and evolution trend thereof 南京财经大学 2019-12-31 CN claimed
US-12590090-B2 Pyrimidine-and nitrogen-containing bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2026-03-31 US disclosed
US-12577258-B2 Macrocyclic compound VERNALIS (R&D) LIMITED (GB) 2026-03-17 US disclosed
EP-4223750-B1 NITROGEN-CONTAINING BICYCLIC COMPOUNDS WHICH CONTAIN PYRIMIDINE AS INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK-4) INHIBITORS TO BE USED IN THE TREATMENT OF INFLAMMATORY OR AUTOIMMUNE DISEASES ASAHI KASEI PHARMA CORP (JP) 2025-06-25 EP disclosed
EP-4223368-B1 MACROCYCLIC COMPOUNDS INCORPORATING PIPERIDINE AND QUINOLINE OR QUNAXOLINE AS IRAK-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS ASAHI KASEI PHARMA CORP (JP) 2025-05-21 EP disclosed
CN-116194454-B Pyrimidine-containing nitrogen-containing bicyclic compounds 旭化成制药株式会社 2025-02-18 CN disclosed
CN-116348472-B Macrocyclic compounds 旭化成制药株式会社 2024-12-03 CN disclosed
US-20240218127-A1 CROWN ETHER-CONTAINING POLYMERS SAUDI ARABIAN OIL COMPANY (SA) 2024-07-04 US disclosed
CN-118255998-A Pterenyl polymer, preparation method and application thereof in anion exchange membrane electrolyzed water 中国科学院上海高等研究院 2024-06-28 CN disclosed
US-20060046983-A1 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY 2006-03-02 US disclosed
WO-2006020082-A1 INHIBITORS OF HCV REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed
WO-2005115398-A2 HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-08 WO disclosed
US-20050261322-A1 HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2005-11-24 US disclosed
WO-2005058837-A1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2005-06-30 WO disclosed
EP-0119107-B1 DERIVATIVES OF BICYCLO(4.2.0)OCTATRIENE-1,3,5, THEIR PREPARATION AND THEIR THERAPEUTICAL APPLICATION ADIR (FR) 1986-10-01 EP disclosed
EP-0119107-A1 Derivatives of bicyclo(4.2.0)octatriene-1,3,5, their preparation and their therapeutical application ADIR (FR) 1984-09-19 EP disclosed
EP-0043194-A3 BICYCLO-OCTATRIENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES AND INTERMEDIATES FOR THEIR PRODUCTION FISONS plc (GB) 1982-03-31 EP disclosed
EP-0043194-A2 Bicyclo-octatriene derivatives, pharmaceutical compositions containing them and processes and intermediates for their production FISONS plc (GB) 1982-01-06 EP disclosed